Colorectal cancer breaks the usual immune rules, with certain regulatory T cells linked to improved survival. In many solid tumors, having a large number of regulatory T (Treg) cells is linked to ...
2don MSN
Microbially produced secondary bile acids accelerate colorectal cancer development, study shows
For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...
In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor. Colorectal cancer, however ...
Robotic-assisted surgery for colorectal cancer (CRC) demonstrated positive outcomes, with minimal blood loss and low conversion rates in 355 cases. The Senhance Robotic System was used in sigmoid ...
Postoperative circulating tumor DNA (ctDNA) positivity strongly predicts worse survival in stage III colon cancer, with ctDNA-positive patients showing sixfold higher recurrence risk. Among ...
While immune checkpoint inhibitors (anti-PD-1 +/- anti-CTLA-4) are approved as first line treatment for microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC), many patients ...
Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO, Norway, June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback